In Brief: Fujisawa's Prograf
Executive Summary
Fujisawa's Prograf: Tacrolimus injection and capsules approved April 22 for prophylaxis of organ rejection in patients receiving allogenic kidney transplants. Prograf was previously indicated only for prophylaxis of liver transplant rejection...